Three patients are described in whom renal cell carcinoma was diagnosed between seven months and 14 years after the onset of ulcerative colitis. All three had required treatment with corticosteroids and azathioprine, as well as maintenance therapy with 5-aminosalicylate derivatives, for chronic active colitis. One patient had coexisting polymyalgia rheumatica; one had primary biliary cirrhosis. It is uncertain whether this association, which has not previously been described, has pathogenetic importance or has arisen simply by chance. Genetic predisposition or the effect of drug treatment, particularly immunosuppression, may be pertinent to the co-occurrence of these diseases. (Gut 1996; 38: 148-150 
Further relapses of colitis were treated with corticosteroids in 1985 and 1986. Azathioprine treatment was reinstituted in 1986 for 18 months but was stopped in 1987. Extensive investigation for pyrexia of unknown origin in 1986 resulted in a diagnosis of polymyalgia rheumatica. In 1994, the patient remained well off all medication and showed no evidence of active colitis or metastatic disease. PATIENT 2 A 48 year old white housewife presented in June 1993 with a two month history of progressive incapacitating diarrhoea, passing up to 12 bloody motions over 24 hours. She also described lower abdominal pain, anorexia, and one stone weight loss. No features in her medical history pointed to an infective cause: stool cultures had twice been negative in preceding weeks. Hypertension had been diagnosed by the general practitioner 12 months before, and treated with atenolol. She smoked 10-15 cigarettes a day.
On examination, the patient was unwell, febrile (37 5°C), and dehydrated. Her blood pressure was 150/90 mm Hg and her weight was 77.3 kg. Abdominal examination showed left sided tenderness. At sigmoidoscopy, the mucosa looked acutely inflamed, granular, and friable. A provisional diagnosis of acute severe ulcerative colitis (confirmed on subsequent histology) was made, and hospital admission was arranged for treatment. Plain abdominal x ray showed mucosal oedema of the left colon and distal transverse colon. Investigation revealed hypokalaemia (2.8 mmol/l), and liver dysfunction-serum bilirubin was 8 ,umol/l (normal range 0-18 ,umolI10, alkaline phosphatase activity was 368 U/l (normal range 80-250 U/1), albumin was 44 g/100 ml, and aspartate aminotransferase activity (AST) 22 U/i (normal range 10-45 U/1).
Treatment with parenteral fluids and corticosteroids induced remission, and the patient was discharged home. Medication on hospital discharge was oral corticosteroids, olsalazine 500 mg twice daily, and atenolol.
At follow up in September 1993 a relapse in symptoms was evident and oral steroids were restarted together with azathioprine (3 mg/kg/d). Azathioprine was stopped after two weeks because of disabling nausea and vomiting which necessitated hospital admission for 48 hours. In December 1993, remission of colitis had been achieved but further investigations of her persistently abnormal liver blood tests were undertaken. Immunology showed a raised titre of antinuclear antibody (1/320) and of anti-mitochondrial antibody (1/160), and normal DNA binding. These features were felt to be most consistent with a diagnosis of primary biliary cirrhosis.
Abdominal ultrasound was performed in January 1994. The liver and common bile ducts looked normal; a solitary gall stone was noted in the gall bladder. However, a heterogeneous mass (6X6 cm) was present in the upper pole of the right kidney. Computed tomogram showed no evidence for spread into the inferior vena cava (Figure) .
Right nephrectomy and needle liver biopsy were carried out in April 1994. No evidence for local spread of tumour was noted. Dramatic haemorrhage from the renal bed necessitated an urgent re-exploration within 12 hours. The history of the resected tumour showed features of clear cell adenocarcinoma. A full recovery was made subsequently. Colonoscopy showed evidence for mild total colitis; endoscopic retrograde cholangiopancreaticography (ERCP) was normal in September 1994.
Right renal cell carcinoma. PATIENT 3 A 55 year old white male accountant, who had smoked 10 cigarettes a day for 35 years, initially presented acutely unwell in July 1989 with high fevers and rigors. Blood culture grew Escherichia coli and mixed anaerobes. The patient was treated with intravenous antibiotics and made a complete recovery. Extensive investigation to determine the source of the sepsis was subsequently performed. Urine culture showed no growth. Abdominal ultrasound showed multiple hepatic cysts, up to 5 cm diameter. Aspiration revealed clear fluid, sterile to culture. Barium enema showed extensive sigmoid diverticular disease but no other pathology. However, flexible sigmoidoscopy showed confluent inflammation affecting the mucosa of the sigmoid colon and rectum. Histology confirmed chronic ulcerative colitis. Maintenance therapy with sulphasalazine (1 g twice daily) was introduced. The patient remained well until February 1993 when he presented with symptoms of acute colitis, passing up to 10 bloody motions over 24 hours.
On examination, he was obese and overweight (101 kg). The blood pressure was 180/100 mm Hg. Abdominal examination showed a large irregular liver. Sigmoidoscopy confirmed acute colitis. Blood tests demonstrated a microcytic anaemia (haemoglobin concentration 11h4 kg/100 ml), raised inflammatory markers (C-reactive protein concentration 115 mg/100 ml; erythrocyte sedimentation rate 42 mm/h), and normal liver and renal functions.
Topical therapy was ineffective and oral prednisolone and azathioprine (1) (2) (3) (4) (5) Therefore, this region may provide candidate susceptibility loci for further studies in ulcerative colitis.
The possible relevance of drug therapy for ulcerative colitis to the development of renal cell carcinoma merits discussion. Each patient had required immunosuppression with systemic steroids and azathioprine in addition to maintenance therapy with sulphasalazine (two patients) or olsalazine. Although impairment of renal function (most commonly caused by interstitial nephritis) has been described in patients taking sulphasalazine6 or mesalazine,7 no reports of neoplasia complicating maintenance therapy with these drugs have been made. It is of potential relevance that phenacetin, a drug with considerable structural homology to 5-aminosalicylic acid, has been implicated in the pathogenesis not only of interstitial nephritis but also renal cell carcinoma.3 Even so, considerable experience with 5-ASA derivatives, especially sulphasalazine, in maintenance therapy of inflammatory bowel disease has accumulated: with this in mind, it seems unlikely that these drugs are involved in the pathogenesis of the neoplasms reported here.
There is considerable concern regarding the prevalence of malignancy in patients treated with long term immunosuppression (in particular azathioprine) either for chronic inflammatory disease or after transplantation. In the present series, one patient had received only two weeks' treatment wit azathiioprine and it seems unlikely that the drug was involved in tumourigenesis. The other patients had received the drug for 10 months and four years respectively before the diagnosis of renal carcinoma. Carcinoma in native kidney10 and dysplasia of the epithelial tissues of a graft kidney" have been recorded. However, renal carcinoma is also a recognised complication in the kidneys of patients with chronic renal failure undergoing haemodialysis, in the absence of any immunosuppression: the relevance of azathioprine in the development of these tumours remains to be proved.
The present report has documented the development of renal cell carcinoma in three patients with ulcerative colitis who had required immunosuppressive therapy. The importance of this co-occurrence is uncertain: the importance of genetic factors may be clarified by cytogenetics or linkage analysis. There is, at present, no definite evidence to implicate drug therapy for ulcerative colitis in the development of these renal tumours.
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